DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $33.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price reduced by Robert W. Baird from $35.00 to $33.00 in a report issued on Friday, Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock.

XRAY has been the topic of several other reports. Piper Sandler increased their price objective on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a neutral rating in a research report on Friday, January 12th. Needham & Company LLC reiterated a buy rating and issued a $42.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Barrington Research reiterated an outperform rating and set a $41.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. StockNews.com upgraded shares of DENTSPLY SIRONA from a hold rating to a buy rating in a research note on Friday, January 19th. Finally, Leerink Partnrs restated an outperform rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of Moderate Buy and a consensus target price of $35.89.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $28.29 on Friday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.95 and a current ratio of 1.43. The company has a market capitalization of $5.87 billion, a price-to-earnings ratio of -64.29, a price-to-earnings-growth ratio of 1.15 and a beta of 1.00. DENTSPLY SIRONA has a one year low of $26.27 and a one year high of $41.65. The company’s 50-day moving average is $32.13 and its 200 day moving average is $32.71.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, meeting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. During the same quarter last year, the firm earned $0.39 earnings per share. The firm’s quarterly revenue was down 2.6% compared to the same quarter last year. Sell-side analysts expect that DENTSPLY SIRONA will post 2.04 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 2.26%. The ex-dividend date was Wednesday, March 27th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

Institutional Trading of DENTSPLY SIRONA

Large investors have recently made changes to their positions in the business. GSA Capital Partners LLP bought a new stake in DENTSPLY SIRONA during the first quarter worth approximately $655,000. Central Pacific Bank Trust Division purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $64,000. Financial Counselors Inc. boosted its holdings in shares of DENTSPLY SIRONA by 4.2% in the 1st quarter. Financial Counselors Inc. now owns 218,576 shares of the medical instruments supplier’s stock worth $7,255,000 after purchasing an additional 8,793 shares during the period. FORA Capital LLC bought a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at approximately $771,000. Finally, Daiwa Securities Group Inc. raised its holdings in DENTSPLY SIRONA by 7.9% during the 1st quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier’s stock valued at $585,000 after buying an additional 1,296 shares during the period. 95.70% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.